Drug-eluting medical implants
Disclosed are self-expanding medical implants for placement within a lumen of a patient. The implants comprise a woven or non-woven structure having a substantially tubular configuration, and are designed to be low-profile such that they are deliverable with a small diameter catheter. The implants have a high recoverability and desired mechanical properties.
1. A medical implant comprising:
a tubular structure comprising
polymeric strands and open spaces between adjacent said polymeric strands, said polymeric strands comprising a first biodegradable material having an elastic modulus within the range of 1 to 10 GPa and that is fully absorbed within a patient;
at least one conformal coating at least partially coating said polymeric strands, said at least one conformal coating comprising paclitaxel and a second biodegradable material that is fully absorbed within a patient;
wherein said tubular structure is characterized by a surface area, and the amount of paclitaxel is within the range of about 0.002 to about 0.175 micrograms per square millimeter of said surface area.
2. The medical implant of claim 1 , wherein said tubular structure comprises at least 32 strands.
3. The medical implant of claim 2 , wherein a cross-sectional diameter of said polymeric strands is within the range of about 0.003 to about 0.007 inches.
4. The medical implant of claim 3 , wherein the amount of paclitaxel is within the range of about 0.002 to about 0.09 micrograms per square millimeter of said surface area.
5. The medical implant of claim 1 , wherein said tubular structure comprises at least 24 strands.
6. The medical implant of claim 5 , wherein a cross-sectional diameter of said polymeric strands is within the range of about 0.003 to about 0.007 inches.
7. The medical implant of claim 6 , wherein the amount of paclitaxel is within the range of about 0.003 to about 0.12 micrograms per square millimeter of said surface area.
8. The medical implant of claim 1 , wherein said tubular structure comprises at least 16 strands.
9. The medical implant of claim 8 , wherein a cross-sectional diameter of said polymeric strands is within the range of about 0.003 to about 0.007 inches.
10. The medical implant of claim 9 , wherein the amount of paclitaxel is within the range of about 0.004 to about 0.175 micrograms per square millimeter of said surface area.
11. The medical implant of claim 1 , wherein said tubular structure comprises a total amount of paclitaxel within the range of about 0.1 to about 2.0 micrograms per millimeter of length of said tubular structure.
12. The medical implant of claim 11 , wherein said tubular structure has a surface area within the range of about 11.4 to about 53.8 square millimeters per millimeter of length of said tubular structure.
13. The medical implant of claim 1 , wherein said tubular structure comprises a total amount of paclitaxel within the range of about 0.2 to about 2.0 micrograms per millimeter of length of said tubular structure.
14. The medical implant of claim 13 , wherein said tubular structure has a surface area within the range of about 11.4 to about 53.8 square millimeters per millimeter of length of said tubular structure.
15. The medical implant of claim 1 , wherein said second conformal coating has a thickness up to 8 microns.
16. The medical implant of claim 1 , wherein said first biodegradable material is different from said second biodegradable material.
17. The medical implant of claim 1 , wherein said first biodegradable material is the same as said second biodegradable material.
18. The medical implant of claim 1 wherein the first biodegradable material has an elastic modulus within the range of 6 to 10 GPa.
19. A medical implant comprising:
a tubular structure comprising
polymeric strands and open spaces between adjacent said polymeric strands, said polymeric strands comprising a first set of polymeric strands having a first cross-sectional diameter and a second set of polymeric strands having a second cross-sectional diameter, said first and second cross-sectional diameters being different from one another, and said first and second set of polymeric strands comprising biodegradable material that is fully absorbed within a patient;
at least one conformal coating at least partially coating said first and second set of polymeric strands, said at least one conformal coating comprising paclitaxel and a second biodegradable material that is fully absorbed within a patient;
wherein said tubular structure is characterized by a surface area, and the amount of paclitaxel is within the range of about 0.002 to about 0.175 micrograms per square millimeter of said surface area.
20. The medical implant according to claim 19 wherein the first and second cross-sectional diameters are each within the range of from about 0.003 inches to about 0.007 inches.